Recent advances in cancer therapy: an overview
- PMID: 20214614
- DOI: 10.2174/138161210789941847
Recent advances in cancer therapy: an overview
Abstract
The landscape of cancer treatment has dramatically changed over the last four decades. The age when surgery and radiotherapy were the only effective way to fight tumour growth has ended. A complex scenario where the molecular features of tumours seem to be the cornerstone of any therapy is now emerging. Here we provide an overview on the different approaches to cancer treatment. This review will help the reader to acknowledge the pivotal role of some classic cancer therapies, including surgery, radiation, chemotherapy and endocrine therapy, now better understood in the mechanims underpinning their efficacy. Following, we focus on the understanding of the value of systemic treatment and on an up-date on the novel, up-coming therapies of the current targeted therapy age, including new antibodies, small molecules, antiangiogenics and viral therapy. We briefly elaborate, finally, on new biomarkers development and how it should rule and determine the future of therapeutic research in cancer.
Similar articles
-
[Strategies of breast cancer treatment based on determination of biological subtype].Vopr Onkol. 2011;57(5):542-52. Vopr Onkol. 2011. PMID: 22238922 Russian. No abstract available.
-
Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?Cancer Treat Rev. 2005 Feb;31(1):1-17. doi: 10.1016/j.ctrv.2004.09.008. Epub 2004 Nov 18. Cancer Treat Rev. 2005. PMID: 15707700 Review.
-
Antiangiogenics and radiotherapy.J Pharm Pharmacol. 2008 Aug;60(8):1029-36. doi: 10.1211/jpp.60.8.0009. J Pharm Pharmacol. 2008. PMID: 18644195 Review.
-
Advances in targeted therapy for unresectable melanoma: new drugs and combinations.Cancer Lett. 2015 Apr 1;359(1):1-8. doi: 10.1016/j.canlet.2014.12.050. Epub 2015 Jan 8. Cancer Lett. 2015. PMID: 25578781 Review.
-
Emerging therapies for adult soft tissue sarcoma.Expert Rev Anticancer Ther. 2014 Jun;14(6):689-704. doi: 10.1586/14737140.2014.885840. Epub 2014 Feb 20. Expert Rev Anticancer Ther. 2014. PMID: 24555529 Review.
Cited by
-
Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice.World J Gastroenterol. 2012 Dec 21;18(47):7079-86. doi: 10.3748/wjg.v18.i47.7079. World J Gastroenterol. 2012. PMID: 23323011 Free PMC article.
-
The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysis.Oncotarget. 2016 Nov 8;7(45):73068-73079. doi: 10.18632/oncotarget.12230. Oncotarget. 2016. PMID: 27683031 Free PMC article.
-
Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear.Yale J Biol Med. 2011 Dec;84(4):371-80. Yale J Biol Med. 2011. PMID: 22180675 Free PMC article. Review.
-
Experiences of Newly Diagnosed Oral Cancer Patients during the First Wave of the COVID-19 Pandemic: A Qualitative Study from Pakistan.Int J Environ Res Public Health. 2022 Jul 12;19(14):8508. doi: 10.3390/ijerph19148508. Int J Environ Res Public Health. 2022. PMID: 35886367 Free PMC article.
-
Efficacy of PD-1/PD-L1 inhibitors against pretreated advanced cancer: a systematic review and meta-analysis.Oncotarget. 2018 Jan 11;9(14):11846-11857. doi: 10.18632/oncotarget.24163. eCollection 2018 Feb 20. Oncotarget. 2018. PMID: 29545941 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources